Effectiveness of Ad26.COV2.S vaccine stable for six months
Mar 22, 2022
A single dose of the Johnson & Johnson vaccine was 74% and 81% effective for preventing COVID-19 infection and hospitalizations, respectively, in the U.S. before and during delta variant surge.
Most immunosuppressive meds not tied to worse COVID-19 outcomes
Dec 01, 2021
Except for rituximab, no increased risk was seen for in-hospital death or mechanical ventilation for those on long-term immunosuppressive therapy.
Decline in infectious conjunctivitis during COVID-19 pandemic
Nov 29, 2021
There was a decrease in emergency department encounters for nonallergic conjunctivitis after the adoption of public health measures to curb COVID-19.
COVID-19 vaccine effectiveness changing with delta predominance
Sep 14, 2021
Vaccine protection against SARS-CoV-2 infection declined; protection remained higher against hospitalization, death.
Fourth COVID-19 vaccine dose safe for immunocompromised
Jul 18, 2022
Local and systemic reactions were reported less frequently after the fourth dose versus dose 3 of the primary vaccination series.
COVID-19 vaccine booster dose cuts infection in those 60 and older
Sep 17, 2021
A large Israeli study shows a reduction in confirmed infection and severe illness among adults 60 years of age and older.
Fourth dose of BNT162b2 offers protection against severe COVID-19
Apr 08, 2022
Protection against COVID-19 did not wane in six weeks after receipt of fourth dose of the Pfizer–BioNTech vaccine; protection against the infection waned.
Survival high with ECMO for selected severe COVID-19 patients
Mar 10, 2022
Of 30 patients, 90% survived to discharge; survival was 86.7% at a median follow-up of 10.8 months since ECMO cannulation.
NVX-CoV2373 vaccine protects against COVID-19
Dec 27, 2021
A study conducted in the U.S. and Mexico shows that the vaccine is 90% effective overall and 100% effective against moderate-to-severe disease.
ACR: Lupus patients can have low immune response to COVID-19 vaccines
Nov 15, 2021
Overall disease activity does not appear to change after vaccination, however.